News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Legionnaires’ disease: what you need to know
World-renowned microbiologist and CEO of Hudson Institute of Medical Research, Professor Elizabeth Hartland, tells you all you need to know about this disease – where it comes from and how to avoid it.… Read more
-
MRFF funding advances Hudson Institute RNA therapies
Hudson Institute of Medical Research has been recognised as a leader in RNA based medicine, with new federal government funding set to accelerate the search for new and better treatments.… Read more
-
Sarcoma accelerator to speed up childhood cancer research
Cancer remains the number-one disease-related killer of Australian children, so a new program at Hudson Institute of Medical Research has been established to specifically target one of the most deadly cancers – sarcoma.… Read more
-
How much creatine is needed for optimal baby growth?
The role of creatine in healthy pregnancies is well established, but how much is enough? A new study at Hudson Institute of Medical Research has shown what’s needed to ensure healthy growth of your baby.… Read more
-
Breakthrough in diagnosing disorders of sex development
A new technique developed at Hudson Institute is set to change how disorders/differences of sex development (DSD) are diagnosed.… Read more
-
Inflammation and stomach cancer: the H. pylori connection
Through a greater understanding of H. pylori infection, we are identifying molecular targets that can be used for better diagnosis, new therapies and preventative treatments, such as vaccines, against the diseases caused by this bacterium.… Read more
-
Grant to improve understanding of UCB stem cell treatment
Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.… Read more
-
Beischer Foundation sticks its ‘NEC’ out
Any new parent will tell you how overwhelming it can feel to suddenly be caring for a fragile new life. Now imagine that this life came into the world before it was ready – the fragility is magnified and with it the number of unknowns and things that can go wrong.… Read more
-
Setting a new PACE for hypertension
The establishment of the Primary Aldosteronism Centre of Research Excellence (PACE), brings together world-class researchers to improve the diagnosis of primary aldosteronism (PA)… Read more
-
Ovarian cancer breakthrough: tiny protein, big impact
Their latest research, published in the esteemed journal, Nature, showed that the innate immune system produces a powerful weapon against ovarian cancer – interferon epsilon (IFNe) – a weapon just waiting to be harnessed to deliver an effective immunotherapy treatment option.… Read more
